Valuation : Medpace Holdings, Inc.

Market Cap 16.77B 14.45B 13.55B 12.36B 23.29B 1,602B 23.37B 161B 62.7B 809B 62.94B 61.57B 2,682B P/E 2026 *
34.2x
P/E 2027 * 31.3x
Enterprise Value 15.96B 13.76B 12.9B 11.77B 22.18B 1,526B 22.25B 153B 59.7B 770B 59.93B 58.63B 2,554B EV / Sales 2026 *
5.6x
EV / Sales 2027 * 5.12x
Free-Float
80.32%
Yield 2026 *
-
Yield 2027 * -
1 day-1.79%
1 week-3.24%
Current month+4.08%
1 month+5.20%
3 months+34.04%
6 months+32.96%
Current year+6.94%
1 week 599.36
Extreme 599.36
625.44
1 month 563.45
Extreme 563.45
629.69
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap.
26/08/26 Sell

Chief Executive Officer

-4,000 0.0143%
24/08/26 Sell

Chief Executive Officer

-1,983 0.0071%
20/08/26 Fiscal year

Chief Financial Officer

10,200 0.0365%
Change 5-day change 1-year change 3-year change Capi.($)
-1.79%-3.24%+27.00%+129.56% 16.77B
-0.78%-1.42%+2.49%+22.78% 50.47B
-6.00%-0.75%+442.41%+544.39% 44.56B
-0.24%+0.74%+38.69%+18.02% 43.08B
-1.55%-2.07%+23.08%+81.47% 41.7B
-0.31%-0.83%+16.15%+51.42% 33.21B
-0.58%-2.12% - - 16.28B
-0.88%-0.66%+11.60%+27.75% 14.58B
-1.66%-1.25%+78.59%+46.66% 13.92B
+0.18%-1.28%-2.87%-33.40% 13.12B
Average -1.36%-1.08%+70.79%+98.74% 28.77B
Weighted average by Cap. -1.62%-1.07%+90.94%+125.55%

Financials

2026 *2027 *
Net sales 2.85B 2.46B 2.3B 2.1B 3.96B 273B 3.97B 27.34B 10.67B 138B 10.71B 10.47B 456B 3.03B 2.61B 2.45B 2.23B 4.21B 289B 4.22B 29.01B 11.32B 146B 11.36B 11.12B 484B
Net income 503M 433M 406M 371M 698M 48.03B 700M 4.82B 1.88B 24.25B 1.89B 1.85B 80.4B 547M 471M 442M 403M 759M 52.24B 762M 5.24B 2.04B 26.37B 2.05B 2.01B 87.44B
Net Debt -802M -691M -648M -592M -1.11B -76.68B -1.12B -7.69B -3B -38.71B -3.01B -2.95B -128B -1.25B -1.08B -1.01B -924M -1.74B -120B -1.75B -12B -4.68B -60.41B -4.7B -4.6B -200B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
28/08/26 $600.65 -1.79% 186,917
27/08/26 $611.57 -1.21% 198,155
26/08/26 $619.05 +0.81% 149,419
25/08/26 $614.06 -0.96% 247,113
24/08/26 $620.03 -0.12% 186,216
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
600.65USD
Average target price
581.83USD
Spread / Average Target
-3.13%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock